Can common drugs tame a racing heart when you stand?
NCT ID NCT00262470
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests several medications to see if they can control the rapid heart rate and symptoms that occur when people with chronic orthostatic intolerance stand up. Researchers will give single doses of drugs like acetazolamide, atomoxetine, clonidine, entacapone, and propranolol to 150 participants. The goal is to find which drug works best to improve daily life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Acetazolamide, Atomoxetine, Clonidine, Entacapone, Propranolol
- What this could lead to
- If successful, this could identify which medications best control heart rate and relieve symptoms for people with orthostatic intolerance.
- What could go wrong
- This is an early-phase trial with single doses, so results may not reflect long-term use. The drugs may cause side effects or not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ORTHOSTATIC INTOLERANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University Autonomic Dysfunction Center
Nashville, Tennessee, 37232-2195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which sedation is best for cataract surgery? new trial aims to find out
- Could a bladder drug help POTS patients stop fainting?
- AI face scan could replace your Doctor's checkup?
- New study gathers heart data to improve future care
- New heart device tested in humans for first time
- New study tracks Real-World use of advanced heart pacemakers